Orchid Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

40.82

40.82

40.82

40.82

88.96

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

691.15

637.14

640.52

1,015.38

-843.95

Loan funds

Secured loans

331.35

267.95

430.34

501.47

2,120.10

Unsecured loans

-

-

-

-

-

Total

1,063.31

945.91

1,111.68

1,557.67

1,365.11

Uses of funds

Fixed assets

Gross block

1,210.07

1,165.92

1,165.67

1,419.94

1,419.36

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

637.01

582.27

495.28

381.13

258.01

Net block

573.06

583.65

670.39

1,038.81

1,161.35

Capital work-in-progress

46.09

9.78

7.43

88.52

278.16

Investments

50.12

49.01

15.43

0.34

0.47

Net current assets

Current assets, loans & advances

553.99

451.74

531.23

584.07

1,553.28

Less : current liabilities & provisions

159.95

148.28

112.79

154.07

1,628.15

Total net current assets

394.04

303.46

418.43

430.00

-74.87

Miscellaneous expenses not written

-

-

-

-

-

Total

1,063.31

945.91

1,111.68

1,557.67

1,365.11

Notes:

Book value of unquoted investments

174.68

173.69

125.04

125.04

125.04

Market value of quoted investments

0.14

0.09

0.13

0.06

0.19

Contingent liabilities

44.91

24.87

45.31

0.97

143.87

Number of equity sharesoutstanding (Lacs)

408.16

408.16

408.16

408.16

889.64